Tango Therapeutics, Inc. · NASDAQ:TNGX
TCG Crossover GP II, LLC reported a 8.10% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
TCG Crossover GP II, LLC reported a 8.10% stake in Tango Therapeutics, Inc., 11,597,737 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 8.10%
- Shares
- 11,597,737
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 8.10% | 11,597,737 |
| TCG Crossover Fund II, L.P. | 8.10% | 11,597,737 |
| Chen Yu | 8.10% | 11,597,737 |
Source
Related
- Tango Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Feb 17, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 14, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026
- Schedule 13G/A · Nextech Crossover I GP S.a. r.l. · Aug 14, 2026